{'52WeekChange': 0.2893437,
 'SandP52WeekChange': 0.0644362,
 'address1': '9 Parker',
 'address2': 'Suite 100',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 54.72,
 'askSize': 800,
 'averageDailyVolume10Day': 259887,
 'averageVolume': 523818,
 'averageVolume10days': 259887,
 'beta': None,
 'beta3Year': None,
 'bid': 54.5,
 'bidSize': 800,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'city': 'Irvine',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 55.72,
 'dayLow': 52.62,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 69.729,
 'enterpriseToRevenue': 7.012,
 'enterpriseValue': 498821152,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 50.102,
 'fiftyTwoWeekHigh': 61.76,
 'fiftyTwoWeekLow': 39.55,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 2197629,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 240,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': None,
 'heldPercentInstitutions': None,
 'industry': 'Medical Devices',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/inarimedical.com',
 'longBusinessSummary': 'Inari Medical, Inc., a commercial-stage medical '
                        'device company, focuses on developing products to '
                        'treat and transform the lives of patients suffering '
                        'from venous diseases in the United States. It '
                        'produces ClotTriever for treatment of deep vein '
                        'thrombosis; and FlowTriever, a thrombectomy system '
                        'for treatment of pulmonary embolism. The company was '
                        'formerly known as Inceptus Newco1 Inc. and changed '
                        'its name to Inari Medical, Inc. in September 2013. '
                        'Inari Medical, Inc. was founded in 2011 and is '
                        'headquartered in Irvine, California.',
 'longName': 'Inari Medical, Inc.',
 'market': 'us_market',
 'marketCap': 2640789760,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_140993984',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 3868003,
 'nextFiscalYearEnd': 1640908800,
 'open': 54.64,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '877-923-4747',
 'previousClose': 55.11,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 37.122833,
 'profitMargins': 0.054369997,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 55.72,
 'regularMarketDayLow': 52.62,
 'regularMarketOpen': 54.64,
 'regularMarketPreviousClose': 55.11,
 'regularMarketPrice': 54.64,
 'regularMarketVolume': 165270,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 48180800,
 'sharesPercentSharesOut': 0.0034,
 'sharesShort': 162709,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 17051,
 'shortName': 'Inari Medical, Inc.',
 'shortPercentOfFloat': 0.0093,
 'shortRatio': 0.49,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'NARI',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 49.327274,
 'volume': 165270,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.inarimedical.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92618'}